rs1553135406
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PVS1PM2PP5
The NM_174936.4(PCSK9):c.85delC(p.Arg29ValfsTer15) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_174936.4 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PCSK9 | ENST00000302118.5 | c.85delC | p.Arg29ValfsTer15 | frameshift_variant | Exon 1 of 12 | 1 | NM_174936.4 | ENSP00000303208.5 | ||
PCSK9 | ENST00000710286.1 | c.442delC | p.Arg148ValfsTer15 | frameshift_variant | Exon 1 of 12 | ENSP00000518176.1 | ||||
PCSK9 | ENST00000673726.1 | n.85delC | non_coding_transcript_exon_variant | Exon 1 of 6 | ENSP00000501004.1 | |||||
PCSK9 | ENST00000673913.2 | n.85delC | non_coding_transcript_exon_variant | Exon 1 of 12 | ENSP00000501161.2 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1415904Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 700006
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
Hypercholesterolemia, familial, 1 Pathogenic:1
- -
not specified Uncertain:1
Variant summary: PCSK9 c.85delC (p.Arg29ValfsX15) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for Hyporcholesterolemia but not for Hypercholesterolemia. The variant was absent in 175998 control chromosomes. To our knowledge, no occurrence of c.85delC in individuals affected with Familial Hypercholesterolemia and no experimental evidence demonstrating its impact on protein function have been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as pathogenic. Hyporcholesterolemia may associate with other symptoms (PMID 20626336). However, this variant is likely to confer protection against coronary artery disease due to its LDLC reducing effect (PMID 24507774). Based on the evidence outlined above, the variant was classified as VUS. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at